Cambridge Bans Use Of Two Toxicity Tests

CAMBRIDGE, MASS.—Medical researchers in this university town are no longer allowed to use two well-known animal toxicity tests after passage of the first legislation of its type in the country. The Cambridge City Council voted May 18 to ban the Classical LD-50 Acute Toxicity Test and the Draize Eye-Irritancy Test. The move is the latest step in a heated local debate on the use of laboratory animals. (A survey by city officials found that at least 50,000 research animals, mostly rats, were

Written bySeth Shulman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Cambridge City Council voted May 18 to ban the Classical LD-50 Acute Toxicity Test and the Draize Eye-Irritancy Test. The move is the latest step in a heated local debate on the use of laboratory animals. (A survey by city officials found that at least 50,000 research animals, mostly rats, were killed last year.)

Only three private laboratories in the city, the largest of which is the well-known consulting firm of Arthur D. Little Inc., are known to use one or both of the banned tests. But the new order is seen as an indication of city council support for two pending ordinances that would more closely regulate animal experimentation by commercial and university laboratories.

Biologist David Baltimore, chief executive officer of MIT's White-head Institute, expressed the fears of many opponents of the two bills by noting that passage could be the first step toward a total ban on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform